REGENSBURG, Germany--(BUSINESS WIRE)--Transcatheter Technologies GmbH, an emerging medical device company that is developing a third-generation transcatheter aortic valve implantation (TAVI) system—Trinity (Click here for video) — announced today the closing of the second tranche of a Series B financing. The company’s founder and CEO, Wolfgang Goetz, M.D., Ph.D., will be looking to meet with additional investors, including potential corporate partners, at the Cardiovascular Research Foundation’s “TVT 2014” meeting in Vancouver starting later this week.
Help employers find you! Check out all the jobs and post your resume.
